Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations

Show simple item record

dc.contributor.author Leung, Yee Fun en
dc.contributor.author Askarian Amiri, Effat en
dc.contributor.author Singleton, Dean en
dc.contributor.author Ferraro-Peyret, Carole en
dc.contributor.author Joseph, Wayne en
dc.contributor.author Finlay, Graeme en
dc.contributor.author Brooms, Reuben J en
dc.contributor.author Kakadiya, Purvibahen en
dc.contributor.author Bohlander, Stefan en
dc.contributor.author Marshall, Elaine en
dc.contributor.author Baguley, Bruce en
dc.date.accessioned 2019-03-05T03:25:13Z en
dc.date.issued 2018-10-12 en
dc.identifier.citation FRONTIERS IN ONCOLOGY 8:12 pages Article number 425 12 Oct 2018 en
dc.identifier.issn 2234-943X en
dc.identifier.uri http://hdl.handle.net/2292/45763 en
dc.language English en
dc.publisher FRONTIERS MEDIA SA en
dc.relation.ispartofseries FRONTIERS IN ONCOLOGY en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.rights.uri http://creativecommons.org/licenses/by/4.0/ en
dc.subject Science & Technology en
dc.subject Life Sciences & Biomedicine en
dc.subject Oncology en
dc.subject breast cancer en
dc.subject PI3K mTOR inhibitor BEZ235 en
dc.subject estrogen receptor en
dc.subject HER2 inhibitors en
dc.subject 5% and 21% oxygen en
dc.subject CA9 en
dc.subject ROS en
dc.subject Triple negative breast cancer (TNBC) en
dc.subject RECEPTOR-RELATED PROTEIN en
dc.subject NEUROFIBROMATOSIS TYPE-1 en
dc.subject EXPRESSION en
dc.subject GENE en
dc.subject NF1 en
dc.subject SENSITIVITY en
dc.subject DEFICIENCY en
dc.subject RESISTANCE en
dc.subject INHIBITORS en
dc.subject MUTATIONS en
dc.title Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations en
dc.type Journal Article en
dc.identifier.doi 10.3389/fonc.2018.00425 en
pubs.volume 8 en
dc.rights.holder Copyright: The authors en
pubs.author-url http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000447130800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=6e41486220adb198d0efde5a3b153e7d en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Article en
pubs.subtype Journal en
pubs.elements-id 755263 en
pubs.org-id Medical and Health Sciences en
pubs.org-id Medical Sciences en
pubs.org-id Auckland Cancer Research en
pubs.org-id Molecular Medicine en
pubs.org-id Science en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
pubs.number ARTN 425 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics